CPHD Share Price

Open 52.95 Change Price %
High 53.00 1 Day 0.00 0.00
Low 52.95 1 Week 0.00 0.00
Close 52.95 1 Month 0.00 0.00
Volume 2651121 1 Year 20.28 62.08
52 Week High 53.91
52 Week Low 25.09
CPHD Important Levels
Resistance 2 53.00
Resistance 1 52.98
Pivot 52.97
Support 1 52.92
Support 2 52.90
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

CEPHEID (NASDAQ: CPHD)

CPHD Technical Analysis 5
As on 4th Nov 2016 CPHD Share Price closed @ 52.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 35.92 & Strong Buy for SHORT-TERM with Stoploss of 49.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
CPHD Target for December
1st Target up-side 53.03
2nd Target up-side 53.09
3rd Target up-side 53.15
1st Target down-side 52.87
2nd Target down-side 52.81
3rd Target down-side 52.75
CPHD Other Details
Segment EQ
Market Capital 2057364736.00
Sector Technology
Industry Scientific & Technical Instruments
Offical website http://www.cepheid.com
CPHD Address
CPHD
904 Caribbean Drive
Sunnyvale, CA 94089
United States
Phone: 408-541-4191
Fax: 408-541-4192
CPHD Latest News
Interactive Technical Analysis Chart CEPHEID ( CPHD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CEPHEID
CPHD Business Profile
Cepheid is a molecular diagnostics company that develops, manufactures and markets fully-integrated systems for testing in the Clinical market, as well as for application in its legacy Non-Clinical market. The Company�s systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company�s two principal systems are the GeneXpert and SmartCycler. The GeneXpert system, its primary offering in the Clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for a broad range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors� offices. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample.